“Pharma Bro” Martin Shkreli, who made himself a public enemy by hiking the price of the HIV medication Daraprim by over 4,100 percent, has been hit with a nine-figure lawsuit from health insurers. The class action suit, filed Thursday in New York district court, accuses the incarcerated executive of “schem[ing] to monopolize the U.S. market” for the life-saving drug. The plaintiffs, Blue Cross and Blue Shield of Minnesota, allege the former hedge-fund manager systematically blocked manufacturers from testing and developing generic versions of the drug. Shkreli, who is currently serving a seven-year sentence for a separate charge of securities fraud, has been sued by the U.S. government over the price changes. But the New York case marks the first legal action against Shkreli from a private company. The 37-year-old and his associates did not respond to Business Insider’s requests for comment.
Read it at InsiderU.S. News
Health Insurers Want Nine Figures From ‘Pharma Bro’ Martin Shkreli
MAD PHARMA
Blue Cross and Blue Shield of Minnesota filed a class action lawsuit against the incarcerated executive on Thursday in the Southern District of New York.
Trending Now